A 'Roz' by any Other Name

A 'Roz' by any Other Name Nicholas Wade's disdainful appraisal of Rosalind Franklin's contribution to solving the structure of DNA is not at all convincing.1 Her social and intellectual snobbery are no more relevant than the fact that Watson and Crick abrogated their gentlemen's agreement with King's College London to abandon DNA work. It is incontrovertible that Watson and Crick would not have come up with their structure were it not for Franklin's understanding of the hydration properties

Written byAbraham Sonenshein
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Nicholas Wade's disdainful appraisal of Rosalind Franklin's contribution to solving the structure of DNA is not at all convincing.1 Her social and intellectual snobbery are no more relevant than the fact that Watson and Crick abrogated their gentlemen's agreement with King's College London to abandon DNA work. It is incontrovertible that Watson and Crick would not have come up with their structure were it not for Franklin's understanding of the hydration properties of DNA, which enabled her to produce appropriate samples for X-ray analysis and to tell them that their first model (and Pauling's) could not be correct because they placed the phosphates on the inside of the molecule.

The only unresolved issue is whether Watson and Crick properly acknowledged her contributions and those of others. As Wade notes, the original paper gave scant credit to others, particularly Franklin, despite the fact that the authors had done no relevant experimental ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies